tiprankstipranks
Kazia Therapeutics Limited (KZIA)
NASDAQ:KZIA
US Market
KZIA
Kazia Therapeutics
RESEARCH TOOLSreports

Kazia Therapeutics (KZIA) Ratios

329 Followers

Kazia Therapeutics Ratios

KZIA's free cash flow for Q2 2026 was AU$0.00. For the 2026 fiscal year, KZIA's free cash flow was decreased by AU$ and operating cash flow was AU$0.00. See a summary of the company’s cash flow.
Ratios
TTM
Jun 25Jun 24Jun 23Jun 22
Liquidity Ratios
Current Ratio
 2.87 0.35 0.24 1.42 1.40
Quick Ratio
 2.87 0.35 0.24 1.42 1.40
Cash Ratio
 2.85 0.31 0.06 0.69 1.09
Solvency Ratio
 -0.90 -1.38 -0.79 -1.16 -1.31
Operating Cash Flow Ratio
 -0.54 -0.94 -0.37 -2.00 -3.38
Short-Term Operating Cash Flow Coverage
 -133.90 -33.53 -15.11 -8.44 -12.36
Net Current Asset Value
AU$ 45.30MAU$ -9.43MAU$ -25.46MAU$ -5.26MAU$ -8.16M
Leverage Ratios
Debt-to-Assets Ratio
 <0.01 0.07 0.03 0.06 0.05
Debt-to-Equity Ratio
 <0.01 -0.05 -0.06 0.15 0.10
Debt-to-Capital Ratio
 <0.01 -0.05 -0.07 0.13 0.09
Long-Term Debt-to-Capital Ratio
 0.00 0.00 0.00 0.00 0.00
Financial Leverage Ratio
 1.53 -0.73 -2.15 2.33 1.96
Debt Service Coverage Ratio
 -167.57 -29.13 -41.52 -12.25 -12.56
Interest Coverage Ratio
 0.00 0.00 0.00 0.00 -12.13K
Debt to Market Cap
 <0.01 0.04 0.08 0.06 0.02
Interest Debt Per Share
 0.03 0.36 1.32 4.87 6.96
Net Debt to EBITDA
 3.82 0.30 0.04 0.15 0.23
Profitability Margins
Gross Profit Margin
100.00%100.00%100.00%100.00%100.00%
EBIT Margin
-92086.45%-33850.00%-1233.19%-4350725.59%-253840.00%
EBITDA Margin
-92090.06%-31626.19%-1152.21%-4013885.95%-235150.00%
Operating Profit Margin
-92086.45%-33850.00%-1233.19%-4346661.08%-253990.00%
Pretax Profit Margin
-122682.95%-53447.62%-1171.97%-3736265.23%-253820.00%
Net Profit Margin
-113004.58%-49290.48%-1160.23%-3687419.82%-250140.00%
Continuous Operations Profit Margin
-114512.21%-49290.48%-1160.23%-3687419.82%-250140.00%
Net Income Per EBT
92.11%92.22%99.00%98.69%98.55%
EBT Per EBIT
133.23%157.90%95.04%85.96%99.93%
Return on Assets (ROA)
-31.35%-341.56%-124.06%-72.87%-69.70%
Return on Equity (ROE)
-116.86%249.39%267.33%-169.84%-136.88%
Return on Capital Employed (ROCE)
-38.87%177.89%675.74%-117.57%-87.10%
Return on Invested Capital (ROIC)
-36.21%172.61%787.50%-106.69%-80.74%
Return on Tangible Assets
-31.84%-416.20%-432.95%-189.23%-149.34%
Earnings Yield
-55.51%-198.39%-342.80%-63.79%-31.03%
Efficiency Ratios
Receivables Turnover
 0.06 0.47 17.35 <0.01 0.20
Payables Turnover
 0.00 0.00 0.00 0.00 0.00
Inventory Turnover
 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
 0.00 0.00 0.00 0.00 0.00
Asset Turnover
 <0.01 <0.01 0.11 <0.01 <0.01
Working Capital Turnover Ratio
 <0.01 >-0.01 -0.28 <0.01 <0.01
Cash Conversion Cycle
 5.84K 782.14 21.03 69.05K 1.86K
Days of Sales Outstanding
 5.84K 782.14 21.03 69.05K 1.86K
Days of Inventory Outstanding
 0.00 0.00 0.00 0.00 0.00
Days of Payables Outstanding
 0.00 0.00 0.00 0.00 0.00
Operating Cycle
 5.84K 782.14 21.03 69.05K 1.86K
Cash Flow Ratios
Operating Cash Flow Per Share
 -4.24 -12.12 -19.98 -41.12 -85.89
Free Cash Flow Per Share
 -2.91 -12.12 -19.98 -41.12 -85.89
CapEx Per Share
 1.33 0.00 0.00 0.00 0.00
Free Cash Flow to Operating Cash Flow
 0.69 1.00 1.00 1.00 1.00
Dividend Paid and CapEx Coverage Ratio
 -3.19 0.00 0.00 0.00 0.00
Capital Expenditure Coverage Ratio
 -3.19 0.00 0.00 0.00 0.00
Operating Cash Flow Coverage Ratio
 -133.90 -33.53 -15.11 -8.44 -12.36
Operating Cash Flow to Sales Ratio
 -670.55 -316.14 -4.15 -27.31K -2.28K
Free Cash Flow Yield
-43.57%-127.25%-122.65%-47.24%-28.24%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 -1.80 -0.50 -0.29 -1.57 -3.22
Price-to-Sales (P/S) Ratio
 1.06K 248.45 3.38 57.81K 8.06K
Price-to-Book (P/B) Ratio
 0.86 -1.26 -0.78 2.66 4.41
Price-to-Free Cash Flow (P/FCF) Ratio
 -2.30 -0.79 -0.82 -2.12 -3.54
Price-to-Operating Cash Flow Ratio
 -3.04 -0.79 -0.82 -2.12 -3.54
Price-to-Earnings Growth (PEG) Ratio
 -0.10 <0.01 0.00 0.04 -0.02
Price-to-Fair Value
 0.86 -1.26 -0.78 2.66 4.41
Enterprise Value Multiple
 2.67 -0.49 -0.26 -1.29 -3.19
Enterprise Value
 -48.47M 6.49M 6.79M 28.64M 75.08M
EV to EBITDA
 2.67 -0.49 -0.26 -1.29 -3.19
EV to Sales
 -2.46K 154.43 2.94 51.60K 7.51K
EV to Free Cash Flow
 5.34 -0.49 -0.71 -1.89 -3.30
EV to Operating Cash Flow
 3.67 -0.49 -0.71 -1.89 -3.30
Tangible Book Value Per Share
 14.53 -8.57 -53.00 -14.16 -3.26
Shareholders’ Equity Per Share
 14.88 -7.58 -20.89 32.69 68.96
Tax and Other Ratios
Effective Tax Rate
 0.07 0.08 0.01 0.01 0.01
Revenue Per Share
 <0.01 0.04 4.81 <0.01 0.04
Net Income Per Share
 -7.14 -18.90 -55.83 -55.52 -94.39
Tax Burden
 0.92 0.92 0.99 0.99 0.99
Interest Burden
 1.33 1.58 0.95 0.86 1.00
Research & Development to Revenue
 398.59 174.43 7.53 28.04K 2.02K
SG&A to Revenue
 604.14 207.62 5.88 15.46K 511.30
Stock-Based Compensation to Revenue
 0.00 15.55 0.23 2.09K 167.50
Income Quality
 0.59 0.64 0.36 0.74 0.91
Currency in AUD